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Abstract
Retinal dopamine depletion in monkeys using either systemic MPTP or 6-OHDA results in attenuated electroretinographic
(ERG) responses to peak spatial frequency stimuli. Diverse dopamine receptors have been identified in the primate retina. ERG
studies performed using Haloperidol (a mixed antagonist), L-Sulpiride (D2 antagonist) and CY 208-243 (a D1 agonist) cause
spatial frequency dependent diverse effects. ‘Tuning’ of the normal spatial contrast response PERG, was quantified by dividing
the amplitude of the response at the peak spatial frequency with the amplitude to the low spatial frequency response yielding a
number greater than one. Tuning for the pharmacological experiments was defined by dividing the actual amplitude obtained at
the normal peak response with the actual amplitude at the low spatial frequency response. The PERG spatial contrast response
function is discussed as the envelope output of retinal ganglion cells or the average or ‘equivalent’ retinal ganglion cell. However,
we postulate the existence of two dopamine sensitive pathways with different weights for two classes of ganglion cells. It is inferred
that D1 receptors are primarily affecting the ‘surround’ organization of ganglion cells with large centers, while D2 post-synaptic
receptors contribute to ‘center’ response amplification of ganglion cells with smaller centers. These inferences are consistent with
some lower vertebrate data. It is also inferred that low affinity D2 autoreceptors may be involved in the D1 ‘surround’ pathway.
An understanding of the logic performed by retinal D1 and D2 receptors may be useful to discern the functional role of diverse
dopamine receptors in DA circuits elsewhere in the CNS. © 1998 Published by Elsevier Science Ltd. All rights reserved.
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1. Introduction
Over the last 20 years our knowledge has consider-
ably expanded concerning the rich network consisting
of lateral and feedback connections at several levels of
the mammalian retina. These interactions undoubtedly
modify signal processing in the straight-through path-
ways culminating in the final ganglion cell output.
Surprisingly enough, information is still scant on details
of how the receptive field of the retinal ganglion cell is
put together. Based on studies in lower vertebrates, it is
assumed that the ‘surround’ in all mammalians is dom-
inated by horizontal cell activity, in the outer plexiform
layer while their influence on the ‘center’ is negligible
[1]. Additional lateral interconnections in the inner
plexiform layer by amacrine cells most certainly partici-
pate in establishing receptive field properties. Various
amacrine cell types are distinguishable by neuro-phar-
macological means. Dopaminergic amacrine cells are
found in all vertebrates including primates. DA
amacrines receive input from other amacrines or di-
rectly from bipolars [2]. In most species DA amacrines
act as interplexiform cells suggesting a role in feedback
circuits. Additionally, they may influence in a lateral
interconnecting circuit other amacrines in the inner
plexiform layer. Their contacts are via conventional
synapses, however DA amacrines may also connect
other neurons through paracrine release of DA. Vari-
ous DA receptors have been identified in several levels
of the mammalian retina, falling into two major classes:
D1 and D2 receptors [3–6].
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We were particularly interested in the role of do-
pamine in vision and particularly, in retinal spatial
processing in man and monkey, and how dopamine
achieves its effect on its main receptor types. In this
paper we summarize previous studies using diverse DA
manipulations in the monkey and provide a synthesis of
these results to propose a model that accounts for the
retinal effects of dopamine on spatial processing. Our
studies were performed using the pattern evoked retino-
gram, the so-called pattern ERG (PERG). It is known
that the PERG represents retinal ganglion cell re-
sponses [7,8]. Hence, results obtained with PERG
recordings reflect the retinal ganglion cell output and
also, indirectly the pre-ganglionic organization of the
retina. Using sinusoidal gratings with different spatial
frequencies as stimuli, it has been established that the
foveal PERG shows a band pass spatial tuning func-
tion. The peak of this function and the descending
limbs are relatable to different organizations and are
differentially vulnerable to neuronal pathology [9]. The
high spatial frequency decline or more pictorially put,
its rise with decreasing spatial frequency, is attributed
to neurons primarily reflecting spatial summation
within the ‘center’ mechanism. The low spatial fre-
quency decline of the PERG on the other hand, repre-
sents the decreasing weight of low spatial frequency
selective neurons of the central retina, either because of
their scarcity or because of their weaker signal due to
strong ‘surround’ dominance of their receptive fields or
for both reasons. It appears that that the low and high
spatial frequency limbs of the PERG are under the
control of diverse dopamine receptors. More specifi-
cally, we suggest that D1 and D2 type receptors, al-
though known to act antagonistically at the cellular
level [10], together synergistically establish the tuned
spatial transfer function in the retina. The PERG spa-
tial tuning function we describe is modeled as the
output of a single ganglion cell with ‘center:surround’
organization; however, based on the evidence dopamine
must act diversely on different type ganglion cells. We
infer that dopamine, the natural neurotransmitter,
modulates spatial contrast responses by a push–pull
effect on ‘center’ and ‘surround’ organizations of differ-
ent ganglion cells in the primate retina.
2. Method
Details of these experiments are described in our
previous publications. Briefly, two methods of depleting
retinal dopamine were used in Macaque monkeys. For
one we used the neurotoxin 6-hydroxydopamine (6-
OHDA), which was first injected into the vitreous of
the eye [11]. It was originally described that this drug
destroys dopaminergic neurons in the nigrostriatal sys-
tem and depletes or decreases dopaminergic neurotrans-
mission [12]. The retinal effect of 6-OHDA was
demonstrated in the carp [13], in the turtle [14], and in
the rabbit [15]. The other dopamine depleting agent we
used was L-methyl-4-phenyl-1,2,5,6-tetahydropyridine
or MPTP [16]. It has been shown that MPTP causes a
Parkinsonian syndrome in monkey and man via it’s
oxidation product, MPP [17]. The monkey model is
behaviorally and pharmacologically near perfect to the
human Parkinsonian disease [18]. MPTP was first
shown to cause DA cell destruction in the rabbit retina
[19]. To create a bilateral Parkinsonian model, we have
used MPTP via systemic injection. In two monkeys,
however, we have used MPTP through intracarotid
injection and observed a hemi-Parkinsonian syndrome
as originally described [20]. Besides dopaminergic neu-
ronal toxins, we have used three types of dopamine
receptor-ligands in the monkey: (a) The D1 receptor
agonist CY208-243, (b) the D2 antagonist L-Sulpiride
[21], and (c) the mixed antagonist, Halopridol. All
drugs were systemically administered. The concentra-
tions of both CY and L-Sulpiride were varied to evalu-
ate if there is a dose-dependent effect of these drugs
(reported only for L-Sulpiride). Each monkey served as
control for the receptor ligand experiments.
The monkeys were trained to accommodate to the
testing environment. During testing we used light ke-
tamine anesthesia 0.2–0.5 mg:kg. Over the years, mon-
keys who were repeatedly tested showed less and less
need for anesthesia for testing and performed without
excessive movements, almost willingly, the experiments.
During the experiment, the monkeys were comfortably
seated and restrained with a harness in a monkey chair
which could be adjusted for their size and weight. They
were facing a high resolution monitor screen (Joyce
electronics). Most studies were performed with monoc-
ular stimulation: one eye had a covering translucent
shield that was held by one of the experimenters while
the head was directed to the screen. The experimenter
watched the monkey’s eyes and when the monkey was
not watching the screen or was not focusing on the
screen the recording was interrupted.
The ERG signals were recorded with skin:needle and
corneal electrodes and amplified with ‘Neuroscientific’
amplifiers. The ‘patttern-reversal’ stimuli were vertical
or horizontal sinusoidal gratings ranging in spatial fre-
quency from 0.25 to 7 cycles per degree. The contrast of
the patterns was 50%. Standing and modulated contrast
were calibrated using methods described in detail previ-
ously [22].
It should be noted that the PERG methods we used
in the monkeys are identical to those used in humans
with Parkinson disease (PD) [23,24]. We found that in
PD, the ratio of the amplitude of the peak response
(which is 3–4 cycles per degree) divided by the response
amplitude to the low spatial frequency response (to 0.5
cycles per degree) provides a derived measure of retinal
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spatial tuning. In this paper we summarize the effect of
dopaminergic manipulations on spatial tuning in the
monkey.
Histological verification of the retinal effects of
MPTP were performed in the laboratories of A Mariani
(NIH). Pharmacological verification of DA, HVA,
VMA levels after MPTP [25] and 6-OHDA were per-
formed in the laboratories of Dr C Mytileneou at Mt
Sinai Hospital.
3. Results
3.1. Summary of dopaminergic effects on the PERG in
the monkey
3.1.1. Retinal spatial tuning in the MPTP primate
model
As a result of systemic MPTP treatment (5 mg:kg)
the monkeys did develop a bilateral Parkinsonian syn-
drome. The simultaneously obtained VEP and PERG
recorded in five monkeys revealed spatial frequency-de-
pendent losses following MPTP treatment [25]. Follow-
ing levodopa treatment, the responses dramatically
improved (Fig. 1). The ratio of the amplitude to the
peak to the low spatial frequency or tuning ratio
changed as a result of MPTP treatment on the average
by a factor of 2; the average tuning ratio of five
monkeys was 0.88 before, (baseline condition) and 0.38
after, MPTP treatment. The relatively low baseline
tuning ratio, 0.88, in this study is probably due to the
fact that the visual field (grating area) was large (30°)
and with a large stimulus field the low spatial frequency
responses tend to be larger both in monkey and man
[26].
3.1.2. The effects of intra6itreal 6-OHDA on spatial
tuning
We studied three monkeys rendered aphakic in order
to avoid possible lens opacities in the 6-OHDA injected
eye. The normal eye served as a control. The monkeys
were refracted before and after injection and the three
aphakic eyes were rendered emmetropic with corrective
spectacle lenses. 6-OHDA was administered i.v. in three
divided doses. ERG recordings were obtained following
each injection of 6-OHDA. ERG responses were ob-
tained for 0.5, 1.2, 2.4 and 3.5 cycles per degree pat-
terns and all recordings procedures were similar to the
study performed with MPTP. In the treated eye the
monocular responses to the 2.5 and 3.5 c:d patterns
were affected similarly to what was seen in each eye of
the systemically treated MPTP monkey. The final re-
sults suggested a profound effect of 6-OHDA in three
monkeys on the responses to 3.5 c:d patterns. Spatial
tuning ratio became less than one in all three monkeys.
The tuning ratio was changed by a factor of 2, 5 and 3,
respectively, in the three monkeys. Hence, the effects of
repeated intraocular injections of 6-OHDA on spatial
tuning were more profound than those of systemic
MPTP.
3.1.3. The effect of the D2 receptor blocker L-Sulpiride
on spatial frequency tuning
Three monkeys were studied. They received Levo-
praide (Ravizza) (L-Sulpiride) injection i.m. L-Sulpiride
has a peak action between 15 and 45 min following i.m.
administration. We recorded the PERG before injection
and then continuously starting 20 min following L-
Sulpiride administration. We separately explored the
effects of 0.07 and 0.35 mg:kg L-Sulpiride, each in three
separate experiments in each monkey. These doses cor-
respond to non-sedating concentrations in humans. The
higher dose depressed responses to all spatial frequen-
cies while the 0.07 mg:kg dose depressed ERG ampli-
tude only at the peak of the spatial frequency curve
(Fig. 2). This in effect changed the tuning ratio from a
number greater than 1 to equal to or smaller than 1 in
all three monkeys. Baseline tuning ratio was roughly
1.5 in one monkey, 1.7 in the other and 1.6 in the third.
Following L-Sulpiride 0.07 mg:kg, the ratio changed to
0.6, to 1, and to 0.5, respectively in the three monkeys,
i.e. by a factor of 2.5, 1.7 and 3.2 [21].
Fig. 1. The effect of the dopamine precursor (levodopa and Car-
bidopa) on the transient PERG in the dopamine deficient monkey
model of Parkinson Disease, induced by MPTP. MPTP causes a
destruction of one set of dopaminergic neurons in the Macaque retina
(see text). Row A and B show the spatial frequency dependent PERG
effect of dopamine in this monkey. For each row, top represents the
PERG following MPTP but prior to acute levodopa treatment. Row
A represents responses 20, row B shows responses 40 days following
the initial MPTP treatment. Notice the transient and spatial fre-
quency dependent effect of levodopa: it increased PERG amplitude
(and slightly decreased latency) for ‘peak’ spatial frequencies without
much effect at low spatial frequencies (coarse pattern stimuli) (after
[16]).
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Fig. 2. The effect of L-Sulpiride on the spatial contrast response PERG is shown for one monkey. The plot represents the average of three runs
for each spatial frequency. Notice that using the lower dose, this D2 receptor substance primarily attenuated peak spatial frequency responses thus
leading to loss of spatial tuning. At the higher dose the D2 receptor blocker suppressed responses to lower spatial frequencies as well. See the text
for a discussion on this interaction of L-Sulpiride dose and spatial frequency (after [21]).
3.1.4. The effect of Haloperidol on the flash ERG
In addition to L-Sulpiride we have explored the ERG
effects of Haloperidol to flash (and not to patterned)
stimuli [27]. Haloperidol increased the amplitude of
both the light and dark adapted flash ERG. Haloperi-
dol is a mixed D1–D2 antagonist and the flash stimulus
is a mixed stimulus, containing energy at very low
spatial frequencies. Based on the effects of L-Sulpiride
and CY 208-243 (see below) one could consider that
Haloperidol is a more potent blocker of D1 than D2
receptors of the retina (see below).
3.1.5. The effect of CY 208-243, a D1 agonist on
spatial tuning
Two lightly anesthetized cynomolgous monkeys were
studied before and after the drug administration. CY
208-243, a D1, agonist has no appreciable effect on
pupillary diameter and intraocular pressure as assessed
by Goldman tonometry. Pupillary measurements fol-
lowed routine clinical methods. The responses were
obtained to a range of spatial frequencies between 0.5
and 6.9 cpd. Our greatest interest was in evaluating
ERG tuning prior to and following the administration
of the D1 agonist drug. In addition, we studied the
effect of a placebo, (sodium chloride 9% solution).
Placebo had no effect on spatial tuning, while the
responses to the low spatial frequency stimulus were
attenuated by the D1 agonist. In fact, responses to low
spatial frequency stimuli did not emerge from noise
following drug administration. (Fig. 3). Attenuating
low spatial frequency responses is the opposite of what
we have observed with Haloperidol, a (mixed) DA
receptor blocker, on the full field flash ERG. It ap-
pears, therefore, that the effect of the D1 agonist at the
low spatial frequency is similar to the effect of the D2
antagonist at the peak spatial frequency: both attenuate
responses. With even the lowest dose of CY 208-243,
this D1 agonist proved to be much more potent to
suppress responses to low spatial frequencies than the
D2 antagonist L-Sulpiride in attenuating medium spa-
tial frequency responses. In sum, therefore, the D1
agonist profoundly attenuates low spatial frequency
responses in contrast to low dose D2 receptor blockade
which attenuates peak spatial frequency responses of
the monkey PERG.
3.2. A synthesis of the experimental results
Our studies, using either 6-OHDA or MPTP show
that the effect of dopamine depletion is a loss of a
bandpass retinal spatial response function. However,
the change was much more profound using 6-OHDA
than MPTP. This difference may be a simple dose-de-
pendent effect or may be the result of subtle differences
of the effects of DA neuronal toxins on diverse retinal
DA amacrine cells. Indeed, Mariani (personal commu-
nication) reported that MPTP affects only one type of
DA amacrine cell. The effect of the D2 blocker L-
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Fig. 3. The effect of an experimental D1 receptor agonist on the low and medium spatial frequency PERG responses. Note that the D1 agonist
selectively ‘attenuated’ (abolished) responses for the low spatial frequency stimulus. Contrast this result with the effect of the high dose D2
antagonist shown in Fig. 1. While both attenuate responses, there is a significant difference concerning spatial frequency. See the text for a
discussion on D2 autoreceptors. (after [49]).
Sulpiride in low concentration is qualitatively the same
as that of DA depletion: peak spatial frequency re-
sponses are attenuated. This similarity suggests that D2
receptors are predominantly post-, rather than pre-
synaptic in the pre-ganglionic retina. However, we have
also observed an attenuation of low spatial frequency
responses following high dose Sulpiride. This result, in
conjunction with the observation that with DA deple-
tion we noticed a mild, albeit not significant, increase of
the PERG amplitude to low spatial frequency stimuli,
could occur if low affinity pre-synaptic D2 auto-recep-
tors were involved in the low spatial frequency path.
The converse and remarkable result was observed with
the D1 agonist (CY 208-243), which predominantly
suppressed low spatial frequency responses. Given that
at low spatial frequencies the high dose D2 antagonist
acted similarly to the D1 agonist, an explanation based
on the existence of D2 auto-receptors is logically cor-
rect. An equal sign effect of the high dose D2 agonist
L-Sulpiride, and the D1 agonist CY 208-243 argue that
low affinity D2 auto-receptors may exist, possibly in the
subset of the dopaminergic pathways using D1 recep-
tors, for regulating low spatial frequency responses.
The following descriptive model, based on the syn-
thesis of our results posits a skeleton of DAs involve-
ment in the neuronal circuitry of the receptive field of
primate retinal ganglion cells. It also leaves aside—for
the time being—the importance of interactions of do-
pamine with other neurotransmitter systems of the
retina [28,29].
First we assume that the PERG spatial tuning func-
tion is an envelope of all ganglion cell responses in the
central retina we stimulated. Given that the PERG
represents ganglion cell responses [8], this is a reason-
able assumption. As a consequence of this assumption,
we postulate that the spatial contrast response function
of the PERG represents the response of the average of
all participating retinal ganglion cells. Alternately
stated, we postulate that the PERG response function is
the envelope of the ‘equivalent’ retinal ganglion cell,
based on the difference of two Gaussians. Secondly, we
base our descriptive model on the retinal ganglion cell
model of Enroth-Cugell and Robson [30]. We realize
however that while their model is based on the sensitiv-
ity profile of the cell, the actual data in our case are
based on higher contrast stimuli and represent a re-
sponse profile.
The spatial summation property of the ‘C’ (center)
and ‘S’ (surround) terms are described with two Gaus-
sians with the following properties: Wc(r)Kc exp[
(r:rc)2] and Ws(r)exp[ (r:rs)2]. These weighting
functions have maxima in the very center of the field,
(the fixation point in our case) as illustrated in Fig. 4.
rcO0 c
2 and rsO0 s
2. For the PERG ‘equiva-
lent’ ganglion cell we used O0 c2 and O0 s8, while
Kc1 and Ks1:5.
We assume that spatial summation of signals in ‘C’
and ‘S’ are altered in DA deficiency as illustrated for
each of these in the bottom of Fig. 4. For both the
‘center’ and ‘surround’ mechanism we postulate a re-
duced height and broadened profile for the DA defi-
cient retina. The approximation we found for the D2
blocked retina is O0 c6 and O0 s10, Kc1:5, Ks1:5.
Fig. 5 illustrates the net effect of altered ‘C’ and ‘S’
mechanisms on the PERG response function in DA
deficiency. With theses constants the DA deficient ERG
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Fig. 4. The Gaussian profiles (left) for center (heavy line) and
surround (interrupted lines) mechanisms for the ‘equivalent’ retinal
ganglion cell (see text). On the right are corresponding spatial sum-
mation profiles. Top: normal retina, bottom DA deficient retina.
Note the attenuated and flattened profiles.
4. Discussion
The basis of our understanding of the receptive field
of retinal ganglion cells stems from Kuffler [31], whose
concept led Stone and Rodieck [32] and Enroth-Cugell
and Robson [30], to develop a quantitative model of the
receptive field of retinal ganglion cells. The model
assumes two antagonistic but cocentered mechanisms
with Gaussian sensitivity profiles: the ‘center’ and ‘sur-
round’. This basic receptive field postulates an algebraic
subtractive interaction of the signals of ‘center’ and
‘surround’ mechanisms. It is likely that neurons with
smallish centers and weak surrounds mediate high spa-
tial frequency responses while neurons with strong sur-
round may dominate when low spatial frequency
stimuli are used. However, the detailed anatomy and
pharmacology of either the receptive field ‘center’ or the
‘surround’ is not known with precision in the primate.
While several studies have been performed on do-
paminergic effects on functional properties of non-pri-
mate retinal ganglion cells, particularly in rabbits
[33–35] and in cats [36–38], the results are not clearly
relatable to primates. Species differences of dopaminer-
gic systems exist between various mammalians both in
terms of morphology [39] and physiology and pharma-
cology. Retinal ganglion cells in the rabbit show direc-
tional selectivity, a major distinguishing feature from
the primate. In cats, while at birth both D1 and D2
receptors are present, adult animals lack functionally
active D1 receptors [40], while our results present evi-
dence for the essential relevance of both D1 and D2
receptors in the adult primate retina.
Fig. 5. PERG response as a function of spatial frequency based on
the ‘equivalent’ retinal ganglion cell profiles of Fig. 3. Heavy line:
normal retina. Interrupted lines: DA deficient retina. The spatial
frequency scale is arbitary. The linear-linear plot (top) would roughly
correspond to experimental data if the spatial frequency scale ‘2’
represented 1 cpd. (see Fig. 1).
response function shows an attenuated tuning ratio by
a factor of 3–4. A relative enhancement of low spatial
frequency responses can also be seen in Fig. 3. This
result is consistent with several of our observations and
neurophysiological studies in other mammalians and
lower vertebrates. However, some observations are not
explained by this simple model as we discuss below, and
two different class of dopamine responsive pathways
need to be postulated. With this assumption, most
available data become internally consistent with the
experimental evidence concerning the role of dopamine
in spatial tuning of the primate retina.
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(1) Based on the similarity of the results obtained
with that MPTP and with 6-OHDA, it is likely that
they both predominantly destroy the type of DA neu-
ron that affects D2 receptors. It is thought that D2
receptors augment coupling between rods and cones in
the frog [41]. Such a mechanism would explain our
results, which show that D2 receptor inactivation results
in decreasing the gain of the receptive field ‘center’
mechanism of retinal ganglion cells. The damage to this
type of DA neurons and:or D2 receptor blockade at
low concentrations, causes attenuated peak spatial fre-
quency responses.
(2) We postulate that a different dopamine depen-
dent pathway modulates horizontal cell coupling via D1
receptors [42] and dopamine in this pathway uncouples
horizontal cells [43–48]. A damage of neurons affecting
this path will allow horizontal cell coupling, dissipating
surround signals and weakening the ‘surround’ organi-
zation of retinal ganglion cells. This effect will be
especially evident on the responses of neurons with
large receptive fields and strong surround organization.
Since coupling is under D1 receptor activation, our
observations of attenuated low spatial frequency re-
sponses under the influence of CY 208-243 [49] are
consistent with this hypothesis only if low spatial fre-
quency responses are mediated by neurons with strong
surround dominance. However, this is a reasonable
postulate.
(3) Furthermore, we suggest that D2 auto-receptors
are involved in the ‘surround’ D1 dopamine pathway in
the primate; blocking them allows a greater DA effect
on D1 receptors and enhances ‘surround’ signals lead-
ing to attenuated low spatial frequency responses as it
is observed [21,50] with high dose L-Sulpiride. When
the surround is weak the neuron becomes a reduced D2
dependent summating device.
(4) Our findings with Haloperidol on the flash ERG
are not inconsistent with the suggestion of the two
dopamine pathways in the retina but neither do they
help to formulate a clear explanation. It is fair to
assume that the effect of this mixed antagonist, primar-
ily via blocking D1 receptors will depend on stimulus
conditions. Interestingly, it has been observed not only
in cold blooded vertebrates but also in rats, that in
horizontal cells full field flash stimuli evoke a smaller
response under the effect of DA than without do-
pamine. Hence, Haloperidol may increase the full field
response of horizontal cells not only in fish but also in
mammalian retina [5]. If indeed Haloperidol reduces
horizontal cell coupling, the result may be an attenua-
tion of the negative feedback of horizontal cells on
receptors. How Haloperidol amplifies horizontal cell
responses to full field simuli and how this effect may
amplify the flash ERG b wave is unclear. The simulta-
neous effect of blocking postsynaptic D1 and D2 recep-
tors can not be easily discerned with the flash ERG, as
Fig. 6. A sketch symbolizing the antagonistic effects of D1 and D2
receptor activation acting on two different arms of the see-saw. As a
consequence, the doubly opposite effects produce an overall synergis-
tic action. The space underneath the curve represents the overall
spatial freqency transfer function of the retina: low frequency decline
occurs where D1 receptors are active. The peak of the curve is created
by the see-saw pointing to the right, where D2 activity is high (from
Bodis-Wollner et al., 1993).
ganglion cells give little signature in the full field flash
response. We have not performed experiments to know
how Haloperidol, by increasing the ‘surround’ response
may influence the PERG. Interactions between the
dopamine and glutamate [28] and GABA [51,52] sys-
tems may occur [28] and will need to be evaluated.
To summarize our results we suggest (Fig. 6) that
dopamine has a push–pull effect in the primate retina:
it strengthens the response of neurons with small cen-
ters and strengthens the surround response of neurons
with large surround. The net result of DA’s push–pull
action, via D1 and D2 receptors, is a tuned spatial
response function, while without DA the function is of
low-pass.
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